author_facet Jonat, W.
Bachelot, T.
Ruhstaller, T.
Kuss, I.
Reimann, U.
Robertson, J.F.R.
Jonat, W.
Bachelot, T.
Ruhstaller, T.
Kuss, I.
Reimann, U.
Robertson, J.F.R.
author Jonat, W.
Bachelot, T.
Ruhstaller, T.
Kuss, I.
Reimann, U.
Robertson, J.F.R.
spellingShingle Jonat, W.
Bachelot, T.
Ruhstaller, T.
Kuss, I.
Reimann, U.
Robertson, J.F.R.
Annals of Oncology
Randomized phase II study of lonaprisan as second-line therapy for progesterone receptor-positive breast cancer
Oncology
Hematology
author_sort jonat, w.
spelling Jonat, W. Bachelot, T. Ruhstaller, T. Kuss, I. Reimann, U. Robertson, J.F.R. 0923-7534 Elsevier BV Oncology Hematology http://dx.doi.org/10.1093/annonc/mdt216 Randomized phase II study of lonaprisan as second-line therapy for progesterone receptor-positive breast cancer Annals of Oncology
doi_str_mv 10.1093/annonc/mdt216
facet_avail Online
Free
finc_class_facet Medizin
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA5My9hbm5vbmMvbWR0MjE2
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA5My9hbm5vbmMvbWR0MjE2
institution DE-Brt1
DE-D161
DE-Zwi2
DE-Gla1
DE-Zi4
DE-15
DE-Pl11
DE-Rs1
DE-105
DE-14
DE-Ch1
DE-L229
DE-D275
DE-Bn3
imprint Elsevier BV, 2013
imprint_str_mv Elsevier BV, 2013
issn 0923-7534
issn_str_mv 0923-7534
language English
mega_collection Elsevier BV (CrossRef)
match_str jonat2013randomizedphaseiistudyoflonaprisanassecondlinetherapyforprogesteronereceptorpositivebreastcancer
publishDateSort 2013
publisher Elsevier BV
recordtype ai
record_format ai
series Annals of Oncology
source_id 49
title Randomized phase II study of lonaprisan as second-line therapy for progesterone receptor-positive breast cancer
title_unstemmed Randomized phase II study of lonaprisan as second-line therapy for progesterone receptor-positive breast cancer
title_full Randomized phase II study of lonaprisan as second-line therapy for progesterone receptor-positive breast cancer
title_fullStr Randomized phase II study of lonaprisan as second-line therapy for progesterone receptor-positive breast cancer
title_full_unstemmed Randomized phase II study of lonaprisan as second-line therapy for progesterone receptor-positive breast cancer
title_short Randomized phase II study of lonaprisan as second-line therapy for progesterone receptor-positive breast cancer
title_sort randomized phase ii study of lonaprisan as second-line therapy for progesterone receptor-positive breast cancer
topic Oncology
Hematology
url http://dx.doi.org/10.1093/annonc/mdt216
publishDate 2013
physical 2543-2548
description
container_issue 10
container_start_page 2543
container_title Annals of Oncology
container_volume 24
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792336079148285955
geogr_code not assigned
last_indexed 2024-03-01T14:54:31.602Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Randomized+phase+II+study+of+lonaprisan+as+second-line+therapy+for+progesterone+receptor-positive+breast+cancer&rft.date=2013-10-01&genre=article&issn=0923-7534&volume=24&issue=10&spage=2543&epage=2548&pages=2543-2548&jtitle=Annals+of+Oncology&atitle=Randomized+phase+II+study+of+lonaprisan+as+second-line+therapy+for+progesterone+receptor-positive+breast+cancer&aulast=Robertson&aufirst=J.F.R.&rft_id=info%3Adoi%2F10.1093%2Fannonc%2Fmdt216&rft.language%5B0%5D=eng
SOLR
_version_ 1792336079148285955
author Jonat, W., Bachelot, T., Ruhstaller, T., Kuss, I., Reimann, U., Robertson, J.F.R.
author_facet Jonat, W., Bachelot, T., Ruhstaller, T., Kuss, I., Reimann, U., Robertson, J.F.R., Jonat, W., Bachelot, T., Ruhstaller, T., Kuss, I., Reimann, U., Robertson, J.F.R.
author_sort jonat, w.
container_issue 10
container_start_page 2543
container_title Annals of Oncology
container_volume 24
description
doi_str_mv 10.1093/annonc/mdt216
facet_avail Online, Free
finc_class_facet Medizin
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTA5My9hbm5vbmMvbWR0MjE2
imprint Elsevier BV, 2013
imprint_str_mv Elsevier BV, 2013
institution DE-Brt1, DE-D161, DE-Zwi2, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3
issn 0923-7534
issn_str_mv 0923-7534
language English
last_indexed 2024-03-01T14:54:31.602Z
match_str jonat2013randomizedphaseiistudyoflonaprisanassecondlinetherapyforprogesteronereceptorpositivebreastcancer
mega_collection Elsevier BV (CrossRef)
physical 2543-2548
publishDate 2013
publishDateSort 2013
publisher Elsevier BV
record_format ai
recordtype ai
series Annals of Oncology
source_id 49
spelling Jonat, W. Bachelot, T. Ruhstaller, T. Kuss, I. Reimann, U. Robertson, J.F.R. 0923-7534 Elsevier BV Oncology Hematology http://dx.doi.org/10.1093/annonc/mdt216 Randomized phase II study of lonaprisan as second-line therapy for progesterone receptor-positive breast cancer Annals of Oncology
spellingShingle Jonat, W., Bachelot, T., Ruhstaller, T., Kuss, I., Reimann, U., Robertson, J.F.R., Annals of Oncology, Randomized phase II study of lonaprisan as second-line therapy for progesterone receptor-positive breast cancer, Oncology, Hematology
title Randomized phase II study of lonaprisan as second-line therapy for progesterone receptor-positive breast cancer
title_full Randomized phase II study of lonaprisan as second-line therapy for progesterone receptor-positive breast cancer
title_fullStr Randomized phase II study of lonaprisan as second-line therapy for progesterone receptor-positive breast cancer
title_full_unstemmed Randomized phase II study of lonaprisan as second-line therapy for progesterone receptor-positive breast cancer
title_short Randomized phase II study of lonaprisan as second-line therapy for progesterone receptor-positive breast cancer
title_sort randomized phase ii study of lonaprisan as second-line therapy for progesterone receptor-positive breast cancer
title_unstemmed Randomized phase II study of lonaprisan as second-line therapy for progesterone receptor-positive breast cancer
topic Oncology, Hematology
url http://dx.doi.org/10.1093/annonc/mdt216